似たピン
DePuy Synthes、Johnson & Johnsonから分離
推定確度 71%281 日後2026年6月28日締め四半期のJ&Jの10-Qは、2025年10月14日の「当初発表から18〜24か月以内の完了」(2027年4月半ば〜10月半ば)を目標としており、Joseph Wolk CFOは7月に、J&Jは「2027年半ばの分離に向け順調だ」と述べた(Bloomberg)。「2027年半ば」は年央、すなわち2027年7月1日と解釈され、この期間内に収まる。[1]Johnson & Johnsonの整形外科事業は、DePuy Synthesとしてグループから分離される見通し。非課税スピンオフか売却かの選択肢があり、Apolloが約200億ドルで交渉中。J&Jは2027年半ばの分離に向け順調だとしている。0.83Apollo in Talks to Buy J&J's DePuy Synthes for About $20 Billion
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United StatesJohnson & Johnson…
確定確度 82%12 日前The disclosure is Bloomberg's report, dated "September 11, 2026" (Yahoo's[1][2][5] syndicated copy went up at 22:26 UTC and quotes Friday's closing share prices); Reuters' write-up the same evening says "Bloomberg News reported on Friday", and Quartz's 14 September story is a follow-up, so the pin is the all-day 11 September.Bloomberg reported that Apollo Global Management is in talks to buy DePuy Synthes, J&J's $9.3 billion-a-year orthopaedics unit, at a value close to $20 billion, with a deal possible within weeks though J&J could still spin the unit off instead.$20B0.76J&J Completes Its $1 Billion Acquisition of Firefly Bio
確定確度 87%56 日前"NEW BRUNSWICK, NJ (July 29, 2026) - Johnson & Johnson (NYSE: JNJ[1][3]) today announced the successful completion of its acquisition of Firefly Bio, Inc. ... for $1 billion in cash"; the 8-K furnishing it gives "Date of report (Date of earliest event reported): July 29, 2026".Johnson & Johnson closed its $1 billion cash purchase of Firefly Bio, the South San Francisco biotech behind the Firelink degrader antibody conjugate platform for KRAS-driven and other hard-to-treat solid tumours.$1B0.66J&J Picks Wilson, North Carolina for a Second 500-Job Drug Plant
確定確度 87%257 日前The governor's release is dated "Friday, January 9, 2026" and begins "Today Governor Josh Stein announced Johnson & Johnson ... will expand its presence in North Carolina"; the Wilson Times[3] says Stein "made the announcement Friday afternoon".North Carolina Governor Josh Stein announced that Johnson & Johnson will build a second multibillion-dollar plant in Wilson, a drug product manufacturing facility for cancer and neurology medicines expected to create up to 500 jobs, beside the $2 billion biologics campus it is already building there.0.63J&J Third-Quarter 2026 Results and Investor Call
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United States
予定確度 73%20 日後Scheduled by J&J's 31 August release: it "will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, October 13th to review third-quarter results" and "The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call"; 8:30 a.m. EDT is 12:30 UTC.[1]Johnson & Johnson releases its third-quarter 2026 results at about 6:45 a.m. Eastern on Tuesday 13 October and reviews them on an 8:30 a.m. investor call hosted by CEO Joaquin Duato and CFO Joseph Wolk.0.62J&J Proposes $5.5 Billion Deal to Settle 76,000 Ovarian Cancer Talc Claims
確定確度 82%58 日前J&J's release is datelined "New Brunswick, N.J. - JULY 27, 2026 - Johnson & Johnson (NYSE: JNJ[1]) ... today announced", and the copy filed as Exhibit 99.1 to its 8-K is marked "FOR RELEASE AT 6:15PM ET", 22:15 UTC in EDT.Johnson & Johnson announced a proposed resolution of its remaining ovarian talc litigation, about 76,000 claims, with a $5.5 billion commitment paid per claim - no more than $3 billion in 2027 and nothing more before 2028 - if at least 95% of claimants take part.$5.5B0.60J&J Q2 2026 Results: $25.3B Sales, 2026 Outlook Raised
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United States
確定確度 83%70 日前Confirmed by J&J's release dated "New Brunswick, N.J. (July 15, 2026)", which says it "will conduct a conference call with investors to discuss this earnings release today at 8:30 a.m., Eastern Time" (12:30 UTC; the edited transcript is stamped "JULY 15, 2026 / 12:30PM GMT").[1]Johnson & Johnson reported second-quarter sales of $25.3 billion, up 6.6%, and adjusted EPS of $2.90, and raised its 2026 outlook to about $101.1 billion in sales and $11.68 adjusted EPS at the midpoint.0.60TSMC's Second Kumamoto Fab (JASM) Starts 3nm Volume Production
推定12 か月遅れ確度 71%2.3 年後Only a year is given: Taiwan's MOEA says the fab is "scheduled to start installing equipment and come online in 2028", and C.C. Wei said on the 16 April 2026 call that "commercial production is scheduled to begin in 2028" - so the year's last day, estimated.[1]JASM's second fab in Kikuyo, Kumamoto - switched from 6nm-class chips to TSMC's 3nm process - is due to start volume production in 2028 at 15,000 12-inch wafers a month, making Japan's first 3nm chips about a year after the end-2027 start TSMC first promised.$17B0.60J&J Signs a Drug-Pricing Deal With Trump and Joins TrumpRx
Johnson & Johnson World Headquarters, 1 Johnson and Johnson Plaza, New Brunswick, New Jersey 08933, United States
確定確度 86%258 日前J&J's release is datelined "New Brunswick, N.J. – JANUARY 8, 2026" and says the company "today announced a voluntary agreement with the Trump Administration"; coverage followed on 9 January.[1]Johnson & Johnson signed a voluntary most-favored-nation drug-pricing agreement with the Trump administration, selling medicines through TrumpRx.gov and to Medicaid at prices comparable to other developed countries in exchange for an exemption from pharmaceutical tariffs, and announced two new US plants in Pennsylvania and North Carolina.0.60JBL Cove Series
確定確度 80%15 日後JBL自身のプレスリリース（https://news.jbl.com[3]/en-CEU/269714-jbl-launches-jbl-cove-a-new-whole-home-audio-system-to-enjoy-superior-sound-throughout-the-entire-home/）は2026年9月1日にCoveシリーズを発表し、スピーカーは「2026年10月8日よりJBL.com[1]でホワイトとブラックの2色で発売される」と記している。このメーカー公表の販売開始日をピンの日付として採用した。JBL独自プラットフォームを採用したワイヤレス・マルチルームスピーカー3機種。0.59B&W and Denham Capital Partner to Repower Coal Plants for Data Centers
確定確度 89%昨年Stated as done, per B&W's release "(AKRON, Ohio – September 10, 2025)": "announced today the signing of a strategic partnership agreement with Denham Capital's[4] Sustainable Infrastructure arm"; the Business Wire copy on Yahoo Finance is timestamped 2025-09-10T10:30:00Z (6:30 a.m. ET).Babcock & Wilcox and Denham Capital's Sustainable Infrastructure arm will jointly convert existing coal-fired plants, largely to natural gas, to power data centres in the US and Europe. B&W supplies the engineering and technology; Denham leads development and financing. No plant is named yet, so the pin sits at B&W's Akron headquarters.0.59TSMC's Dresden Fab (ESMC) Starts Production
推定確度 73%1.3 年後TSMC's[1][6] founding release gives a bound, not a day: "production targeted to begin by the end of 2027"; at the September 2026 topping-out the partners still said production starts in 2027 and Hardwareluxx[3] reported tool installation "bis Ende 2027", after which the first chips follow - so 31 December 2027, estimated.ESMC, TSMC's EUR 10 billion joint venture with Bosch, Infineon and NXP, is due to start production at its Dresden fab by the end of 2027 - Europe's first FinFET-capable foundry, making 28/22nm and 16/12nm chips mainly for cars and industry.€10B0.59
